World Bank Approves $12B In Financing To Help Developing Countries Procure, Distribute Coronavirus Vaccines, Tests, Treatments; Mexico Signs With 3 Companies To Purchase Potential Vaccines

AP: World Bank approves $12B to finance virus vaccines, care
“The World Bank has approved $12 billion in financing to help developing countries buy and distribute coronavirus vaccines, tests, and treatments, aiming to support the vaccination of up to 1 billion people. The $12 billion ‘envelope’ is part of a wider World Bank Group package of up to $160 billion to help developing countries fight the COVID-19 pandemic, the bank said in a statement late Tuesday. The World Bank said its COVID-19 emergency response programs are already reaching 111 countries…” (10/14).

Wall Street Journal: Mexico Signs Agreements to Buy Potential Covid-19 Vaccines
“Mexico signed agreements with three companies on Tuesday that are developing vaccines against Covid-19, and it expects to secure doses for more than 100 million people through 2021. Mexico will buy eventual vaccines for 39 million people from AstraZeneca PLC of the U.K., as many as 17 million from Pfizer Inc. and 35 million from China’s CanSino Biologics Inc. It’s also participating in the international vaccine alliance Covax, through which it expects to obtain doses for about 26 million people…” (Harrup, 10/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.